Selective cyclooxygenase 2 inhibitor NS-398 induces apoptosis in myeloma cells via a Bcl-2 independent pathway

Ristimaki A, 1994, J Biol Chem, 269, 11769, 10.1016/S0021-9258(17)32638-8

Turull A, 2001, Inflammation, 25, 119, 10.1023/A:1007122706770

10.1074/jbc.C100140200

O'Byrne KJ, 2001, Br J Cancer, 85, 473, 10.1054/bjoc.2001.1943

Edwards JG, 2002, Clin Cancer Res, 8, 1857

Schroer K, 2002, Circulation, 105, 2760, 10.1161/01.CIR.0000018127.10968.34

Giles FJ, 2002, Br J Haematol, 119, 38, 10.1046/j.1365-2141.2002.03784.x

10.1016/S0006-291X(03)01079-9

Kune GA, 1998, Cancer Res, 48, 4399

Davies G, 2003, Clin Cancer Res, 9, 2651

Kikuchi T, 2002, Int J Cancer, 97, 272, 10.1002/ijc.1612

10.1074/jbc.M107829200

Kondo M, 1999, Clin Cancer Res, 5, 4005

Rahman MA, 2000, Cancer Res, 60, 2085

Attiga FA, 2000, Cancer Res, 60, 4629

His LC, 2000, Exp Cell Res, 256, 563, 10.1006/excr.2000.4863

Michaluart P, 1999, Cancer Res, 59, 2347

Buttar NS, 2002, Gastroenterology, 22, 1101, 10.1053/gast.2002.32371

10.1016/0006-2952(96)00181-5

10.1097/00062752-199801000-00008

Fosslien E., 2001, Ann Clin Lab Sci, 31, 325

10.1038/sj.bjc.6600347

Takahira H, 1994, Exp Hematol, 22, 261

Sheng H, 1998, Cancer Res, 58, 362

Stolina M, 2000, J Immunol, 164, 361, 10.4049/jimmunol.164.1.361

10.1046/j.1365-2141.1998.01101.x

Repovic P, 2003, Glia, 42, 433, 10.1002/glia.10182

Mori N, 2001, Int J Cancer, 94, 813, 10.1002/ijc.1544

Randy JL, 2001, Int J Cancer, 62, 7372

10.1073/pnas.95.2.681

10.1056/NEJM199911183412102

10.1006/bbrc.2001.5928

10.1016/S0955-0674(99)80034-9

Souza RF, 2000, Cancer Res, 60, 5767

10.1126/science.278.5341.1305

10.1126/science.281.5381.1309

10.1126/science.275.5303.1129

Jendrossek V, 2003, FASEB J, 17, 1547, 10.1096/fj.02-0947fje